Loss of estrogen receptor β isoform expression and its correlation with aberrant DNA methylation of the 5′‐untranslated region in human epithelial ovarian carcinoma

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Cancer Science

• Publication date

  2008-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1111/j.1349-7006.2008.00988.xPMID 19032364PMCID PMC11159089
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Genome-wide allelic imbalance analysis of pediatric gliomas by single nucleotide polymorphic allele array.

  2006cited by this paper
• Estrogen receptor (ER)-β isoforms: A key to understanding ER-β signaling

  2006cited by this paper
• Estrogen receptor (ER)-beta isoforms: a key to understanding ER-beta signaling.

  2006cited by this paper
• Ovarian clear cell adenocarcinoma: a continuing enigma

  2006cited by this paper
• Progesterone receptor isoforms as a prognostic marker in human endometrial carcinoma

  2006cited by this paper
• Aberrant methylations in cancer cells: Where do they come from?

  2005cited by this paper
• Estrogen receptor beta inhibits human breast cancer cell proliferation and tumor formation by causing a G2 cell cycle arrest.

  2004cited by this paper
• Dynamic regulation of estrogen receptor-beta expression by DNA methylation during prostate cancer development and metastasis.

  2004cited by this paper
• Evaluation of mRNA expression of estrogen receptor β and its isoforms in human normal and neoplastic endometrium

  2004cited by this paper
• Involvement of Estrogen Receptor β in Ovarian Carcinogenesis

  2004cited by this paper
• Estrogen receptor mutations in human disease.

  2004cited by this paper
• Estrogen Receptor β Inhibits Human Breast Cancer Cell Proliferation and Tumor Formation by Causing a G2 Cell Cycle Arrest

  2004cited by this paper
• Involvement of estrogen receptor beta in ovarian carcinogenesis.

  2004cited by this paper
• Expression of estrogen receptor beta isoforms in normal breast epithelial cells and breast cancer: regulation by methylation.

  2003cited by this paper
• Estrogen receptor (ER) beta1 and ERbetacx/beta2 inhibit ERalpha function differently in breast cancer cell line MCF7.

  2003cited by this paper
• Estrogen receptor (ER) β1 and ERβcx/β2 inhibit ERα function differently in breast cancer cell line MCF7

  2003cited by this paper
• Expression of estrogen receptor beta isoforms in human breast cancer tissues and cell lines

  2002cited by this paper
• Differential Expression of Estrogen Receptor β (ERβ) and Its C-Terminal Truncated Splice Variant ERβcx as Prognostic Predictors in Human Prostatic Cancer

  2001cited by this paper
• Expression of estrogen receptor (ER) subtypes and ERbeta isoforms in colon cancer.

  2001cited by this paper
• Prognostic factors of stage IV epithelial ovarian cancer: a multicenter retrospective study.

  2001cited by this paper
• A role for estrogen receptor β in the regulation of growth of the ventral prostate

  2001cited by this paper
• Expression of 5α‐Reductases in Human Epithelial Ovarian Cancer: Its Correlation with Androgen Receptor Status

  2001cited by this paper
• A gene hypermethylation profile of human cancer.

  2001cited by this paper
• Differential expression of estrogen receptor beta (ERbeta) and its C-terminal truncated splice variant ERbetacx as prognostic predictors in human prostatic cancer.

  2001cited by this paper
• The multiple untranslated first exons system of the human estrogen receptor beta (ERβ) gene

  2001cited by this paper
• The multiple untranslated first exons system of the human estrogen receptor beta (ER beta) gene.

  2001cited by this paper
• Characterization and tumorigenicity of human ovarian surface epithelial cells immortalized by SV40 large T antigen.

  2001cited by this paper
• Absence of Estrogen Receptor‐β Expression in Metastatic Ovarian Cancer

  2000cited by this paper
• Absence of estrogen receptor-beta expression in metastatic ovarian cancer.

  2000cited by this paper
• Progesterone receptor isoforms A and B in human epithelial ovarian carcinoma: immunohistochemical and RT-PCR studies

  2000cited by this paper
• Expression of estrogen receptor beta1, beta2, and beta5 messenger RNAs in human breast tissue.

  1999cited by this paper
• Estrogen receptor-beta messenger RNA expression in human breast tumor biopsies: relationship to steroid receptor status and regulation by progestins.

  1999cited by this paper
• Molecular cloning and characterization of human estrogen receptor βcx: A potential inhibitor of estrogen action in human

  1998cited by this paper
• Cloning and Characterization of Human Estrogen Receptor β Isoforms

  1998cited by this paper
• Estrogen receptor alpha (ER-alpha) and beta (ER-beta) mRNAs in normal ovary, ovarian serous cystadenocarcinoma and ovarian cancer cell lines: down-regulation of ER-beta in neoplastic tissues.

  1998cited by this paper
• Cloning and characterization of human estrogen receptor beta isoforms.

  1998cited by this paper
• Differential Expression of Estrogen Receptor-α and -β Messenger RNAs as a Potential Marker of Ovarian Carcinogenesis

  1998cited by this paper
• Toward the development of a universal grading system for ovarian epithelial carcinoma. I. Prognostic significance of histopathologic features--problems involved in the architectural grading system.

  1998cited by this paper
• Molecular cloning and characterization of human estrogen receptor betacx: a potential inhibitor ofestrogen action in human.

  1998cited by this paper
• Estrogen receptor alpha (ER-α) and beta (ER-β) mRNAs in normal ovary, ovarian serous cystadenocarcinoma and ovarian cancer cell lines : Down-regulation of ER-β in neoplastic tissues

  1998cited by this paper
• Differential expression of estrogen receptor-alpha and -beta messenger RNAs as a potential marker of ovarian carcinogenesis.

  1998cited by this paper
• The nuclear receptor superfamily: the second decade.

  1995cited by this paper
• Epidermal growth factor, oestrogen and progesterone receptor expression in primary ovarian cancer: correlation with clinical outcome and response to chemotherapy.

  1995cited by this paper
• Responsiveness of patients with advanced ovarian carcinoma to tamoxifen. A gynecologic oncology group study of second‐line therapy in 105 patients

  1991cited by this paper
• DNA methylation and gene expression

  1991cited by this paper
• Endocrine factors in common epithelial ovarian cancer.

  1991cited by this paper
• CpG islands in vertebrate genomes.

  1987cited by this paper
• Cytoplasmic progesterone and estradiol receptors in normal, hyperplastic, and carcinomatous endometria: therapeutic implications.

  1981cited by this paper
• Steroid receptors in human breast cancer.

  1978cited by this paper
• The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright © 2000 by The Endocrine Society Estrogen Receptor Isoform Gene Expression in Ovarian

  year unknowncited by this paper

• Emerging Trends and Treatment Strategies in Ovarian Cancer: A Comprehensive Review.

  2026cites this paper
• Progress of estrogen receptor and spliceosome in endometrial carcinoma

  2025cites this paper
• Role of DNA methylation and non‑coding RNAs expression in pathogenesis, detection, prognosis, and therapy‑resistant ovarian carcinoma (Review)

  2025cites this paper
• Perinatal exposure to bisphenol A impairs the Mongolian gerbil ovarian follicle dynamics and its extracellular milieu

  2025cites this paper
• Primary Carcinomas of the Episiotomy Scar Site: A Systematic Literature Review

  2025cites this paper
• ENDOMETRIOSIS-ASSOCIATED OVARIAN CANCER, FROM RISK FACTORS TO SURVIVAL RATE: A SYSTEMATIC REVIEW AND META-ANALYSIS

  2025cites this paper
• Epigenetic Modulation of Estrogen Receptor Signaling in Ovarian Cancer

  2024cites this paper
• New insights about endometriosis-associated ovarian cancer: pathogenesis, risk factors, prediction and diagnosis and treatment

  2024cites this paper
• Pharmacological inhibition of KDM1A/LSD1 enhances estrogen receptor beta-mediated tumor suppression in ovarian cancer.

  2023cites this paper
• Role of Estrogen Receptor β, G-Protein Coupled Estrogen Receptor and Estrogen-Related Receptors in Endometrial and Ovarian Cancer

  2023influential citation
• Estrogen Receptors-Mediated Apoptosis in Hormone-Dependent Cancers

  2022cites this paper
• Estradiol Signaling at the Heart of Folliculogenesis: Its Potential Deregulation in Human Ovarian Pathologies

  2022cites this paper
• Identification of epigenetic regulators in the estrogen signaling pathway via siRNA screening.

  2021cites this paper
• Histone deacetylase inhibitors enhance estrogen receptor beta expression and augment agonist-mediated tumor suppression in glioblastoma

  2021cites this paper
• Correlation of clinicopathological and prognostic characteristics between endometriosis-associated and primary ovarian cancer

  2021cites this paper
• Estrogen Receptor Beta: The Promising Biomarker and Potential Target in Metastases

  2021cites this paper
• Methylation of ERβ 5′‐untranslated region attenuates its inhibitory effect on ERα gene transcription and promotes the initiation and progression of papillary thyroid cancer

  2021cites this paper
• Estrogen Signaling and Its Potential as a Target for Therapy in Ovarian Cancer

  2020influential citation
• A methylation signature at the CpG island promoter of estrogen receptor beta (ER-β) in breasts of women may be an early footmark of lack of breastfeeding and nulliparity.

  2020cites this paper
• Indole Derivative Interacts with Estrogen Receptor Beta and Inhibits Human Ovarian Cancer Cell Growth

  2020cites this paper
• Endometriosis and ovarian cancer: Their association and relationship

  2019cites this paper
• Size, site, and signaling: Three attributes of estrogen receptors

  2019cites this paper
• Accelerometer-measured Physical Activity, Reproductive Hormones, and DNA Methylation.

  2019cites this paper
• Epigenetic Biomarkers in the Management of Ovarian Cancer: Current Prospectives

  2019cites this paper
• Aberrant DNA methylation defines isoform usage in cancer, with functional implications

  2019cites this paper
• Differential Effects of Estrogen Receptor β Isoforms on Glioblastoma Progression.

  2018cites this paper
• Mechanisms for estrogen receptor expression in human cancer

  2018cites this paper
• Three cases of clear‐cell adenocarcinoma arising from endometrioma during hormonal treatments

  2018cites this paper
• Structural and functional characteristics of oestrogen receptor β splice variants: Implications for the ageing brain

  2018cites this paper
• Exploring the effects of estrogen receptor beta polymorphisms on wound repair

  2017cites this paper
• Estrogen receptor beta modulates prostate carcinogenesis

  2017cites this paper
• Molecular Bases of Chemoresistance in Cholangiocarcinoma.

  2017cites this paper
• Effect of estrogen receptor β agonists on proliferation and gene expression of ovarian cancer cells

  2017cites this paper
• Gene Expression Profiling Reveals Novel Candidate Markers of Ovarian Carcinoma Intraperitoneal Metastasis

  2017cites this paper
• Xenoestrogen regulation of ERα/ERβ balance in hormone-associated cancers.

  2017cites this paper
• Comprehensive assessment of estrogen receptor beta antibodies in cancer cell line models and tissue reveals critical limitations in reagent specificity

  2017cites this paper
• Differential expression of estrogen receptor subtypes and variants in ovarian cancer: effects on cell invasion, proliferation and prognosis

  2017cites this paper
• Hormone receptor expression profile of low-grade serous ovarian cancers.

  2017cites this paper
• Estrogen receptor expression and gene promoter methylation in non-small cell lung cancer - a short report

  2016cites this paper
• Germline ESR2 mutation predisposes to medullary thyroid carcinoma and causes up-regulation of RET expression.

  2016cites this paper
• Molecular Background of Estrogen Receptor Gene Expression in Endometriotic Cells

  2016cites this paper
• Multiple direct and indirect mechanisms drive estrogen-induced tumor growth in high grade serous ovarian cancers

  2016cites this paper
• Estrogen receptor β promoter methylation: a potential indicator of malignant changes in breast cancer

  2016cites this paper
• Estrogen receptor beta and ovarian cancer: a key to pathogenesis and response to therapy

  2016cites this paper
• Estrogen receptor β agonist enhances temozolomide sensitivity of glioma cells by inhibiting PI3K/AKT/mTOR pathway.

  2015cites this paper
• Mitochondrial estrogen receptor β2 drives antiapoptotic pathways in advanced serous ovarian cancer.

  2015cites this paper
• The expression and correlation between the transcription factor FOXP1 and estrogen receptors in epithelial ovarian cancer.

  2015cites this paper
• The role of reproductive hormones in epithelial ovarian carcinogenesis.

  2015cites this paper
• Epithelial Ovarian Cancers and Endometriosis

  2015cites this paper
• Estrogen receptor-beta genetic variations and overall survival in patients with locally advanced gastric cancer

  2015cites this paper
• Estrogen Biosynthesis and Action in Ovarian Cancer

  2014cites this paper
• Malignant transformation of endometriosis

  2014cites this paper
• Xenoestrogens challenge 17β-estradiol protective effects in colon cancer.

  2014cites this paper
• Estrogen receptor beta in prostate cancer: friend or foe?

  2014cites this paper
• Increased steroid receptor RNA activator protein (SRAP) accompanied by decreased estrogen receptor-beta (ER-β) levels during the malignant transformation of endometriosis associated ovarian clear cell carcinoma.

  2014cites this paper
• The many faces of estrogen signaling

  2014cites this paper
• Prognostic significance of the estrogen receptor beta (ERβ) isoforms ERβ1, ERβ2, and ERβ5 in advanced serous ovarian cancer.

  2014cites this paper
• Involvement of estrogen receptor β5 in the progression of glioma.

  2013cites this paper
• Endometriosis-Associated Ovarian Cancer: A Review of Pathogenesis

  2013cites this paper
• Common single-nucleotide polymorphisms in the estrogen receptor β promoter are associated with colorectal cancer survival in postmenopausal women.

  2013cites this paper
• Transcription Factor-MicroRNA-Target Gene Networks Associated with Ovarian Cancer Survival and Recurrence

  2013cites this paper
• Estrogen receptor alpha/beta ratio and estrogen receptor beta as predictors of endocrine therapy responsiveness–a randomized neoadjuvant trial comparison between anastrozole and tamoxifen for the treatment of postmenopausal breast cancer

  2013cites this paper
• Potential clinical significance of ERβ ON promoter methylation in sporadic breast cancer

  2013cites this paper
• PES1 differentially regulates the expression of ERα and ERβ in ovarian cancer

  2013cites this paper
• New insights on the role of hormonal therapy in ovarian cancer.

  2013cites this paper
• Regulation of estrogen receptor β1 expression in breast cancer by epigenetic modification of the 5' regulatory region.

  2013cites this paper
• Biology and Clinical Relevance of Estrogen Receptors in Prostate Cancer

  2013cites this paper
• Identification and characterization of gene and microRNA networks associated with cancer survival and drug abuse

  2013cites this paper
• 17β-estradiol residue determined in minced meat and it’s Carcinogencity in mice

  2013cites this paper
• The role of H1 linker histone variants in ovarian cancer

  2013cites this paper
• Title : Common single nucleotide polymorphisms in the estrogen receptor β promoter are associated with colorectal cancer survival in postmenopausal women Authors and Affiliations :

  2012cites this paper
• Estrogen receptor beta in cancer: an attractive target for therapy.

  2012cites this paper
• Expression des Östrogenrezeptors beta beim humanen duktalen Pankreasadenokarzinom und Inhibition der Tumorprogression durch Einsatz des selektiven Östrogenrezeptormodulators Raloxifen

  2012cites this paper
• Régulation dynamique de l’activité du récepteur des estrogènes beta (ERβ) par la phosphorylation,l’ubiquitination et la sumoylation

  2012cites this paper
• Expression of DNA methyltransferases in the mouse uterus during early pregnancy and susceptibility to dietary folate deficiency.

  2012cites this paper
• Epithelial Ovarian Cancer – Adjuvant Measures with Potential for Slowing Its Spread and Boosting or Restoring its Chemosensitivity

  2012cites this paper
• Role of estrogen receptor β in gynecological cancer.

  2012influential citation
• Modulation of estrogenic action in clear cell carcinoma of the ovary (Review).

  2012cites this paper
• Hormone response in ovarian cancer: time to reconsider as a clinical target?

  2012cites this paper
• An oestrogen receptor β-selective agonist exerts anti-neoplastic effects in experimental intrahepatic cholangiocarcinoma.

  2012cites this paper
• Functional Characterization of a Genetic Polymorphism in the Promoter of the ESR2 Gene

  2012cites this paper
• Potential Role of Estrogen Receptor Beta as a Tumor Suppressor of Epithelial Ovarian Cancer

  2012cites this paper
• High-throughput detection of aberrant imprint methylation in the ovarian cancer by the bisulphite PCR-Luminex method

  2012cites this paper
• Estrogen receptors and human disease: an update

  2012cites this paper
• Ovarian Actions of Estrogen Receptor-β: An Update

  2012cites this paper
• Role of estrogen and estrogen receptors in cancer pathology

  2011cites this paper
• Risk of carcinoma in women with ovarian endometrioma.

  2011cites this paper
• In Silico discovery of transcription factors as potential diagnostic biomarkers of ovarian cancer

  2011cites this paper
• The different roles of ER subtypes in cancer biology and therapy

  2011cites this paper
• Expression of ERα, its ERαΔ3 Splice Variant and γ-SYNUCLEIN in Ovarian Cancer: A Pilot Study.

  2011cites this paper
• ERβ1 represses FOXM1 expression through targeting ERα to control cell proliferation in breast cancer.

  2011cites this paper
• The role of estrogen receptor beta (ERbeta) in malignant diseases--a new potential target for antiproliferative drugs in prevention and treatment of cancer.

  2010cites this paper
• Oestrogen receptor splice variants in the pathogenesis of disease.

  2010cites this paper
• The importance of ERbeta signalling in the ovary.

  2010cites this paper
• The importance of ER b signalling in the ovary

  2010influential citation
• The Role of Oestrogen Receptor ß in Ovarian Granulosa Cell Tumours

  2010influential citation
• The importance of ERb signalling in the ovary

  2010influential citation
• Modulation of gene expression in ovarian cancer by active and repressive histone marks.

  2010cites this paper
• Epigenetic effects of endocrine-disrupting chemicals on female reproduction: an ovarian perspective.

  2010cites this paper
• Epigenetics of ovarian cancer: from the lab to the clinic.

  2010cites this paper